olsalazine has been researched along with Colorectal Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cun, JE; Gao, W; Gu, Z; He, B; Li, J; Luo, K; Pan, Q; Pu, Y; Zhang, Z | 1 |
Hanauer, SB; Huo, D; LoSavio, A; Rubin, DT; Yadron, N | 1 |
Brown, WA; Farmer, KC; Malcontenti-Wilson, C; Misajon, A; O'Brien, PE; Skinner, SA | 1 |
3 other study(ies) available for olsalazine and Colorectal Cancer
Article | Year |
---|---|
Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Colorectal Neoplasms; Copper; Cyclooxygenase 2; Epigenesis, Genetic; Hyaluronic Acid; Hydrogen Peroxide; Ligands; Metal-Organic Frameworks; Mice; Nanoparticles | 2022 |
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Case-Control Studies; Chemoprevention; Chronic Disease; Colitis, Ulcerative; Colorectal Neoplasms; Female; Humans; Logistic Models; Male; Middle Aged; Precancerous Conditions; Sulfasalazine | 2006 |
5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer.
Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Colorectal Neoplasms; Disease Models, Animal; Male; Mesalamine; Rats; Rats, Sprague-Dawley | 2000 |